Title : ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial.

Pub. Date : 2013 Jun 22

PMID : 23799908






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study is designed to investigate the ability of udenafil, a newly developed long-acting PDE5 inhibitor, to improve functional capacity and hemodynamic status in a cohort of chronic systolic heart failure (SHF) patients. udenafil phosphodiesterase 5A Homo sapiens